These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22961571)

  • 1. Insulin regimens and clinical outcomes in a type 1 diabetes cohort: the SEARCH for Diabetes in Youth study.
    Pihoker C; Badaru A; Anderson A; Morgan T; Dolan L; Dabelea D; Imperatore G; Linder B; Marcovina S; Mayer-Davis E; Reynolds K; Klingensmith GJ;
    Diabetes Care; 2013 Jan; 36(1):27-33. PubMed ID: 22961571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of insulin regimens and impact on outcomes in youth with type 1 diabetes: the SEARCH for Diabetes in Youth study.
    Paris CA; Imperatore G; Klingensmith G; Petitti D; Rodriguez B; Anderson AM; Schwartz ID; Standiford DA; Pihoker C
    J Pediatr; 2009 Aug; 155(2):183-9.e1. PubMed ID: 19394043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    Lo C; Jun M; Badve SV; Pilmore H; White SL; Hawley C; Cass A; Perkovic V; Zoungas S
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD009966. PubMed ID: 28238223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensive vs. conventional insulin management initiated at diagnosis in children with diabetes: should payer source influence the choice of therapy?
    Beck JK; Lewis TV; Logan KJ; Harrison DL; Gardner AW; Copeland KC
    Pediatr Diabetes; 2009 Sep; 10(6):368-73. PubMed ID: 19522746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Socio-economic, demographic, and clinical correlates of poor glycaemic control within insulin regimens among children with Type 1 diabetes: the SEARCH for Diabetes in Youth  Study.
    Snyder LL; Stafford JM; Dabelea D; Divers J; Imperatore G; Law J; Lawrence JM; Pihoker C; Mayer-Davis EJ
    Diabet Med; 2019 Aug; 36(8):1028-1036. PubMed ID: 31050009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of Treatment Intensification on A1c in Patients with Suboptimally Controlled Type 2 Diabetes After 2 Oral Antidiabetic Agents.
    Kim K; Unni S; McAdam-Marx C; Thomas SM; Sterling KL; Olsen CJ; Johnstone B; Mitchell M; Brixner D
    J Manag Care Spec Pharm; 2019 Mar; 25(3):314-322. PubMed ID: 30816811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parental mastery of continuous subcutaneous insulin infusion skills and glycemic control in youth with type 1 diabetes.
    Mitchell K; Johnson K; Cullen K; Lee MM; Hardy OT
    Diabetes Technol Ther; 2013 Jul; 15(7):591-5. PubMed ID: 23799273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Insulin Regimen and Estimated Body Fat Over Time among Youths and Young Adults with Type 1 Diabetes: The SEARCH for Diabetes in Youth Study.
    Kahkoska AR; Sarteau AC; Igudesman D; Reboussin BA; Dabelea D; Dolan LM; Jensen E; Wadwa RP; Pihoker C; Mayer-Davis EJ
    J Diabetes Res; 2022; 2022():1054042. PubMed ID: 35127949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
    Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
    Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin regimens, diabetes knowledge, quality of life, and HbA1c in children and adolescents with type 1 diabetes.
    Keller M; Attia R; Beltrand J; Djadi-Prat J; Nguyen-Khoa T; Jay JP; Cahané M; Choleau C; Robert JJ
    Pediatr Diabetes; 2017 Aug; 18(5):340-347. PubMed ID: 27161814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous subcutaneous insulin infusion versus multiple daily injections: the impact of baseline A1c.
    Retnakaran R; Hochman J; DeVries JH; Hanaire-Broutin H; Heine RJ; Melki V; Zinman B
    Diabetes Care; 2004 Nov; 27(11):2590-6. PubMed ID: 15504991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A bridge to insulin pump therapy: twice-daily regimen with NPH and detemir insulins during initial treatment of youth with type 1 diabetes mellitus.
    Cengiz E; Sherr JL; Erkin-Cakmak A; Weinzimer SA; Burke EN; Sikes KA; Urban AD; Tamborlane WV
    Endocr Pract; 2011; 17(6):862-6. PubMed ID: 21550949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes Device Use and Glycemic Control among Youth with Type 1 Diabetes: A Single-Center, Cross-Sectional Study.
    Sheikh K; Bartz SK; Lyons SK; DeSalvo DJ
    J Diabetes Res; 2018; 2018():5162162. PubMed ID: 30151393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Initiation of Diabetes Devices Relates to Improved Glycemic Control in Children with Recent-Onset Type 1 Diabetes Mellitus.
    Patton SR; Noser AE; Youngkin EM; Majidi S; Clements MA
    Diabetes Technol Ther; 2019 Jul; 21(7):379-384. PubMed ID: 31166808
    [No Abstract]   [Full Text] [Related]  

  • 15. Changes in insulin therapy regimens over 10 yr in children and adolescents with type 1 diabetes attending diabetes camps.
    Redon I; Beltrand J; Martin D; Taupin P; Choleau C; Morandini M; Cahané M; Robert JJ;
    Pediatr Diabetes; 2014 Aug; 15(5):329-35. PubMed ID: 24016246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study.
    Raccah D; Sulmont V; Reznik Y; Guerci B; Renard E; Hanaire H; Jeandidier N; Nicolino M
    Diabetes Care; 2009 Dec; 32(12):2245-50. PubMed ID: 19767384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of race/ethnicity on the efficacy and safety of commonly used insulin regimens: a post hoc analysis of clinical trials in type 2 diabetes mellitus.
    Davidson JA; Lacaya LB; Jiang H; Heilmann CR; Scism-Bacon JL; Gates JR; Jackson JA
    Endocr Pract; 2010; 16(5):818-28. PubMed ID: 20439249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    Lo C; Toyama T; Oshima M; Jun M; Chin KL; Hawley CM; Zoungas S
    Cochrane Database Syst Rev; 2020 Jul; 8(8):CD009966. PubMed ID: 32803882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study.
    Hirsch IB; Abelseth J; Bode BW; Fischer JS; Kaufman FR; Mastrototaro J; Parkin CG; Wolpert HA; Buckingham BA
    Diabetes Technol Ther; 2008 Oct; 10(5):377-83. PubMed ID: 18715214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re-examining a measure of diabetes-related burden in parents of young people with Type 1 diabetes: the Problem Areas in Diabetes Survey - Parent Revised version (PAID-PR).
    Markowitz JT; Volkening LK; Butler DA; Antisdel-Lomaglio J; Anderson BJ; Laffel LM
    Diabet Med; 2012 Apr; 29(4):526-30. PubMed ID: 21883443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.